Genetic Markers Could Predict Prostate Cancer in Younger Men
Researchers believe that genetics and traditional screening methods could play a role in predicting the risk of prostate cancer in younger men.
Read MoreSearch Results for: genetic testing
News Story #15790
FDA Grants Quest Diagnostics Simplexa 2009 H1N1 Test 501(k) Clearance Quest Diagnostics Inc has announced that the FDA has issued 510(k) clearance to the Simplexa™ Influenza A H1N1 (2009) test on the 3M™ integrated cycler. The Simplexa test,
Read More
Mass Spectrometry: An Emerging Path for Clinical Diagnostics
As diagnostics come to depend on increasingly sophisticated knowledge of biomarkers, mass spec emerges as a tool with revolutionary potential.
Read MoreMolecular Diagnostic Experts Identify Keys to Continued Growth
The 2010 Molecular Diagnostics conference surpassed all expectations as the event’s faculty of thought leaders isolated the drivers and unique challenges of the fastest growing segment of the $55 billion clinical laboratory industry.
Read MoreConsumer Genetics Conference to Discuss Policies, Challenges and Advancements
Preeminent thought leaders from government, health care, biotechnology, and DTC companies will convene in Boston, from June 2 to 4, at the Hynes Convention Center for the second annual Consumer Genetics Conference.
Read More